PDE4B and esophageal cancer: Furthermore, treatment of immunodeficient mice bearing esophageal cancer xenografts (TE1 cell-derived) with alvespimycin hydrochloride (AH, an HSP90AA1 inhibitor) or ML-030 (a PDE4B inhibitor) remarkably suppressed tumor growth (Fig. 5e–g).